Skip to Main content Skip to Navigation
Journal articles

Zebrafish as a preclinical model for Extracellular Vesicle-based therapeutic development

Abstract : Extracellular Vesicles (EVs) are released during various pathophysiological processes and reflect the state of their cell of origin. Once released, they can propagate through biological fluids, target cells, deliver their content and elicit functional responses. These specific features would allow their harnessing as biomarkers, drug nano-vehicles and therapeutic intrinsic modulators. However, the further development of their potential therapeutic application is hampered by the lack of knowledge about how EVs behave in vivo. Recent advances in the field of imaging EVs in vivo now allow live-tracking of endogenous and exogenous EV in various model organisms at high spatiotemporal resolution to define their distribution, half-life and fate. This review highlights current imaging tools available to image EVs in vivo and how live imaging especially in the zebrafish embryo can bring further insights into the characterization of EVs dynamics, biodistribution and functions to potentiate their development for therapeutic applications.
Complete list of metadata

https://www.hal.inserm.fr/inserm-03357931
Contributor : Clara Martinez Rico Connect in order to contact the contributor
Submitted on : Wednesday, September 29, 2021 - 10:01:47 AM
Last modification on : Thursday, October 7, 2021 - 3:10:47 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Alexandre Androuin, Frederik Verweij, Guillaume van Niel. Zebrafish as a preclinical model for Extracellular Vesicle-based therapeutic development. Advanced Drug Delivery Reviews, Elsevier, 2021, 176, pp.113815. ⟨10.1016/j.addr.2021.05.025⟩. ⟨inserm-03357931⟩

Share

Metrics

Record views

13